HIGHLIGHTS
- who: Top from the Department of Radiation Oncology, The Affiliated Cancer Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China have published the research work: IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent, in the Journal: (JOURNAL)
- what: From this study, IMRT combined with concurrent chemotherapy followed by adjuvant chemotherapy in NPC might improve the 1-,2-,and 3- year OS, but no significant difference were observed between the two groups.
- how: For those small sample data the authors used the fisher . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.